Juno teams with AstraZeneca to explore new therapy, foot the bill for clinical trial

April 23, 2015 5:05 PM

4 0

Juno teams with AstraZeneca to explore new therapy, foot the bill for clinical trial

Seattle biotech Juno Therapeutics is teaming up with British pharmaceutical company AstraZeneca to explore the potential of combining two of their drug products into one therapy. Under the new collaboration, the two companies will also co-fund a clinical trial together.

Juno (Nasdaq: JUNO) will work directly with MedImmune, the research and development arm of AstraZeneca (Nasdaq: AZN) to explore how well one of Juno's drug candidates works with a product from MedImmune with the goal of better understanding how those drugs work.

Read more

To category page

Loading...